Roselie E Achten
6PUBLICATIONS
14CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Sep 24, 2025
Biologics to Treat Atopic Dermatitis: Effectiveness, Safety, and Future Directions.Marjolein S de Bruin-Weller, Celeste M Boesjes, Roselie A Achten
|Feb 09, 2024
Ocular surface disease in moderate-to-severe atopic dermatitis patients and the effect of biological therapy.Roselie Achten, Judith Thijs, Marlot van der Wal
|Mar 19, 2023
Dupilumab-associated ocular surface disease in atopic dermatitis patients: Clinical characteristics, ophthalmic treatment response and conjunctival goblet cell analysis.Roselie Achten, Judith Thijs, Marlot van der Wal
|Jan 27, 2023
High dupilumab levels in tear fluid of atopic dermatitis patients with moderate-to-severe ocular surface disease.Roselie Achten, Judith Thijs, Marlot van der Wal
|Dec 23, 2022
Biomarkers in tear fluid of dupilumab-treated moderate-to-severe atopic dermatitis patients.Roselie Achten, Judith Thijs, Chantal van Luijk
|Mar 16, 2022
Ocular surface disease is common in moderate-to-severe atopic dermatitis patients.Roselie E Achten, Daphne S Bakker, Chantal M van Luijk
Pageof 1
Frequent Collaborators
5 joint publications
Marjolein S de Bruin-Weller
5 joint publications
Daphne S Bakker
4 joint publications
Judith Thijs
2 joint publications
Celeste M Boesjes
2 joint publications
Chantal van Luijk
2 joint publications
Edward Knol
2 joint publications
Marlot van der Wal
2 joint publications
Marlies de Graaf
2 joint publications
Joke H de Boer
1 joint publications
Alan D Irvine
